Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Trevi Therapeutics
TRVI
$2.59B
| $121K | ﹤0.01% |
35,195
-28,602
| -45% | -$63.8K |
|
4227
RCM Technologies
RCMT
$201M
| $121K | ﹤0.01% |
5,679
-4,342
| -43% | -$120K |
|
4228
iShares US Healthcare Providers ETF
IHF
$1.21B
| $121K | ﹤0.01% |
2,225
| – | – |
|
4229
State Street SPDR S&P China ETF
GXC
$462M
| $121K | ﹤0.01% |
1,844
| – | – |
|
4230
Innodata
INOD
$2.05B
| $121K | ﹤0.01% |
18,331
-17,161
| -48% | -$143K |
|
4231
MediciNova
MNOV
$65.5M
| $121K | ﹤0.01% |
83,200
-8,100
| -9% | -$11.5K |
|
|
SLN
4232
Silence Therapeutics
SLN
$495M
| $120K | ﹤0.01% |
+5,570
| New | +$121K |
|
4233
Forafric Global
AFRI
$289M
| $120K | ﹤0.01% |
11,578
-3,356
| -22% | -$35.2K |
|
4234
CALL
Coherus Oncology
CHRS
$217M
| $119K | ﹤0.01% |
+49,900
| New | +$123K |
|
|
4235
PUT
Coherus Oncology
CHRS
$217M
| $119K | ﹤0.01% |
+49,900
| New | +$123K |
|
4236
Rimini Street
RMNI
$449M
| $119K | ﹤0.01% |
36,539
-35,187
| -49% | -$112K |
|
4237
AMES National
ATLO
$271M
| $119K | ﹤0.01% |
5,899
-5,820
| -50% | -$114K |
|
4238
ProShares Bitcoin Strategy ETF
BITO
$1.41B
| $119K | ﹤0.01% |
3,671
-187,600
| -98% | -$4.72M |
|
|
EGRX
4239
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $118K | ﹤0.01% |
22,590
-6,993
| -24% | -$38.4K |
|
4240
BlackSky Technology
BKSY
$943M
| $118K | ﹤0.01% |
10,837
-9,869
| -48% | -$108K |
|
4241
DLH Holdings
DLHC
$70.7M
| $118K | ﹤0.01% |
8,881
| – | – |
|
|
IFN
4242
Aberdeen India Fund
IFN
$499M
| $118K | ﹤0.01% |
6,632
+150
| +2% | +$2.96K |
|
4243
Vitamin Cottage Natural Grocers
NGVC
$739M
| $118K | ﹤0.01% |
6,524
-16,010
| -71% | -$257K |
|
4244
RGC Resources
RGCO
$223M
| $118K | ﹤0.01% |
5,811
-5,252
| -47% | -$101K |
|
|
SQNS
4245
Sequans Communications SA
SQNS
$36.4M
| $118K | ﹤0.01% |
+12,215
| New | +$586K |
|
4246
Rackspace Technology
RXT
$1.05B
| $118K | ﹤0.01% |
74,399
-42,664
| -36% | -$76.5K |
|
4247
908 Devices
MASS
$329M
| $118K | ﹤0.01% |
15,568
-14,545
| -48% | -$108K |
|
|
SVM
4248
Silvercorp Metals
SVM
$2.07B
| $117K | ﹤0.01% |
35,987
-237
| -0.7% | -$604 |
|
4249
EVI Industries
EVI
$181M
| $117K | ﹤0.01% |
4,710
-1,857
| -28% | -$40.8K |
|
4250
Princeton Bancorp
BPRN
$281M
| $114K | ﹤0.01% |
3,717
-3,278
| -47% | -$105K |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.